VENATORX PHARMACEUTICALS INC
Federal contract awards won by VENATORX PHARMACEUTICALS INC (UEI MBBKNBU5DCC6), 2016–2023 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
6
awards
$300,888,470
total value
2
agencies
Agencies buying from VENATORX PHARMACEUTICALS INC
What VENATORX PHARMACEUTICALS INC sells
Awards
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
Department of Health and Human Services · $26,449,853 · Sep 15, 2023
VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS
Department of Health and Human Services · $72,141,707 · Sep 27, 2022
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Department of Health and Human Services · $10,669,276 · Jul 1, 2020
VENATORX PHARMACEUTICALS, INC.
Department of Health and Human Services · $131,756,814 · Jul 17, 2019
PENICILLIN BINDING PROTEINS IGF::OT::IGF
Department of Defense · $14,716,733 · Aug 28, 2017
IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
Department of Health and Human Services · $45,154,088 · Sep 19, 2016
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids